BR9810520A - Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial - Google Patents
Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterialInfo
- Publication number
- BR9810520A BR9810520A BR9810520-5A BR9810520A BR9810520A BR 9810520 A BR9810520 A BR 9810520A BR 9810520 A BR9810520 A BR 9810520A BR 9810520 A BR9810520 A BR 9810520A
- Authority
- BR
- Brazil
- Prior art keywords
- factor
- combination
- arterial thrombosis
- inhibitor alone
- aggregator
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Patente de Invenção: <B>"INIBIDOR DO FATOR Xa ISOLADO OU EM COMBINAçãO COM UM ANTI-AGREGADOR PLAQUETáRIO, CONTRA A TROMBOSE ARTERIAL"<D>. A invenção refere-se à utilização de inibidores seletivos diretos ou indiretos do fator Xa que age via a antitrombina III, isolados ou em combinação com um ou vários compostos de atividade antiagregadora plaquetária, para o preparo de medicamentos destinados a prevenir a tratar as doenças tromboembólicas arteriais. Constituem igualmente o objetivo da invenção, composições farmacêuticas contendo um ou vários inibidores seletivos diretos ou indiretos do fator Xa que age via antitrombina III em associação com um ou vários compostos com atividade antiagregadora plaquetária, e, eventualmente, um ou vários veículos farmaceuticamente aceitáveis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9707368A FR2764511B1 (fr) | 1997-06-13 | 1997-06-13 | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
PCT/FR1998/001172 WO1998056365A1 (fr) | 1997-06-13 | 1998-06-09 | INHIBITEUR DU FACTEUR Xa SEUL OU EN COMBINAISON AVEC UN ANTIAGREGANT PLAQUETTAIRE, CONTRE LA THROMBOSE ARTERIELLE |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9810520A true BR9810520A (pt) | 2000-09-19 |
Family
ID=9507960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9810520-5A BR9810520A (pt) | 1997-06-13 | 1998-06-09 | Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial |
Country Status (43)
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2764511B1 (fr) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
US6344450B1 (en) | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
WO2000047207A1 (en) | 1999-02-09 | 2000-08-17 | Bristol-Myers Squibb Company | LACTAM INHIBITORS OF FXa AND METHOD |
FR2793687B1 (fr) * | 1999-04-26 | 2001-08-24 | Sanofi Sa | Nouvelle composition injectable d'un anticoagulant |
FR2800074B1 (fr) * | 1999-10-22 | 2001-12-21 | Aventis Pharma Sa | Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant |
US6544981B2 (en) | 2000-06-09 | 2003-04-08 | Bristol-Myers Squibb Company | Lactam inhibitors of factor Xa and method |
US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
EP1370570B1 (en) * | 2001-02-28 | 2007-01-24 | John H. Griffin | Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein c |
UA80399C2 (en) * | 2001-11-13 | 2007-09-25 | Glaxo Group Ltd | Use of specific dose of fondaparinux sodium for the treatment of acs |
US20040067995A1 (en) | 2002-10-02 | 2004-04-08 | Wong Pancras C. | Novel combination of a factor Xa inhibitor and clopidogrel |
WO2004048363A1 (ja) * | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | イミダゾール誘導体、その製造法および用途 |
EP1679067A4 (en) * | 2003-09-19 | 2010-04-07 | Kissei Pharmaceutical | COMBINED MEDICINES |
WO2005087266A1 (en) * | 2004-03-05 | 2005-09-22 | Vddi Pharmaceuticals | Combination therapy for inhibition of platelet aggregation |
CN101820537B (zh) * | 2004-04-23 | 2013-04-03 | 住友电气工业株式会社 | 活动图像数据的编码方法、终端装置以及双向对话型*** |
TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
US7563780B1 (en) * | 2004-06-18 | 2009-07-21 | Advanced Cardiovascular Systems, Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
JP5557410B2 (ja) * | 2004-07-13 | 2014-07-23 | 第一三共株式会社 | 経口投与による血栓・塞栓の予防治療剤 |
US20070105825A1 (en) * | 2004-09-16 | 2007-05-10 | Yuji Hoyano | Concurrent drugs |
EP1991272A2 (en) * | 2005-10-10 | 2008-11-19 | N.V. Organon | Antithrombotic compound |
US20110150976A1 (en) * | 2008-09-10 | 2011-06-23 | Transpharma Medical Ltd. | Transdermal delivery of oligosaccharides |
WO2011149110A1 (en) | 2010-05-28 | 2011-12-01 | Daiichi Sankyo Company, Limited | Novel composition for the prevention and/or treatment of thromboembolism |
JP6389009B2 (ja) * | 2014-10-30 | 2018-09-12 | チェンデュ バイユ ファーマシューティカル カンパニー リミテッドChengdu Baiyu Pharmaceutical Co.,Ltd. | ギンコライドBと第Xa因子阻害剤とを含有する薬物組成物及びその製造方法と用途 |
CN106860868B (zh) * | 2015-12-11 | 2019-11-22 | 北京百奥药业有限责任公司 | 沙班类药物与蚓激酶的药物组合物、制剂及其应用 |
US11654036B2 (en) | 2020-05-26 | 2023-05-23 | Elixir Medical Corporation | Anticoagulant compounds and methods and devices for their use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2548189B1 (fr) * | 1983-07-01 | 1986-04-11 | Choay Sa | Nouveaux produits contenant des oligosaccharides, leur preparation et leurs applications biologiques et biochimiques |
ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
FR2728901B1 (fr) * | 1994-12-28 | 1997-03-28 | Sanofi Sa | Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
IL129877A (en) | 1996-11-27 | 2004-08-31 | Aventis Pharm Prod Inc | A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent |
FR2764511B1 (fr) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
-
1997
- 1997-06-13 FR FR9707368A patent/FR2764511B1/fr not_active Expired - Lifetime
-
1998
- 1998-06-09 UA UA99126569A patent/UA70919C2/uk unknown
- 1998-06-09 DK DK98929521T patent/DK0986376T3/da active
- 1998-06-09 CZ CZ0446099A patent/CZ299518B6/cs not_active IP Right Cessation
- 1998-06-09 BR BR9810520-5A patent/BR9810520A/pt not_active Application Discontinuation
- 1998-06-09 CN CNB988081202A patent/CN1253150C/zh not_active Expired - Lifetime
- 1998-06-09 EE EEP199900574A patent/EE04737B1/xx unknown
- 1998-06-09 WO PCT/FR1998/001172 patent/WO1998056365A1/fr active IP Right Grant
- 1998-06-09 SI SI9830906T patent/SI0986376T1/sl unknown
- 1998-06-09 ME MEP-1999-636A patent/ME00685B/me unknown
- 1998-06-09 IL IL13345298A patent/IL133452A/en not_active IP Right Cessation
- 1998-06-09 ID IDW991574A patent/ID29309A/id unknown
- 1998-06-09 SK SK1709-99A patent/SK286311B6/sk not_active IP Right Cessation
- 1998-06-09 AU AU79246/98A patent/AU728826B2/en not_active Expired
- 1998-06-09 NZ NZ501452A patent/NZ501452A/en not_active IP Right Cessation
- 1998-06-09 EP EP98929521A patent/EP0986376B1/fr not_active Expired - Lifetime
- 1998-06-09 ES ES98929521T patent/ES2299209T3/es not_active Expired - Lifetime
- 1998-06-09 US US09/445,555 patent/US6541488B1/en not_active Expired - Lifetime
- 1998-06-09 PL PL98337288A patent/PL193405B1/pl unknown
- 1998-06-09 CA CA2293415A patent/CA2293415C/en not_active Expired - Lifetime
- 1998-06-09 RU RU2000100812/14A patent/RU2212886C2/ru active
- 1998-06-09 AT AT98929521T patent/ATE384528T1/de active
- 1998-06-09 TR TR1999/03087T patent/TR199903087T2/xx unknown
- 1998-06-09 RS YUP-636/99A patent/RS49902B/sr unknown
- 1998-06-09 JP JP50176599A patent/JP3988803B2/ja not_active Expired - Lifetime
- 1998-06-09 KR KR1019997011705A patent/KR100598451B1/ko not_active IP Right Cessation
- 1998-06-09 PT PT98929521T patent/PT986376E/pt unknown
- 1998-06-09 HU HU0002175A patent/HU227956B1/hu unknown
- 1998-06-09 DE DE69839046T patent/DE69839046T2/de not_active Expired - Lifetime
- 1998-06-10 DZ DZ980122A patent/DZ2512A1/xx active
- 1998-06-10 CO CO98033125A patent/CO4940476A1/es unknown
- 1998-06-12 TW TW087109401A patent/TW565442B/zh not_active IP Right Cessation
- 1998-06-12 UY UY25044A patent/UY25044A1/es not_active IP Right Cessation
- 1998-06-12 AR ARP980102794A patent/AR012247A1/es not_active Application Discontinuation
- 1998-06-12 HR HR980322A patent/HRP980322B1/xx not_active IP Right Cessation
- 1998-06-12 ZA ZA985137A patent/ZA985137B/xx unknown
- 1998-06-13 MY MYPI98002643A patent/MY124648A/en unknown
- 1998-09-15 SA SA98190552A patent/SA98190552B1/ar unknown
- 1998-10-29 GT GT199800171A patent/GT199800171A/es unknown
-
1999
- 1999-11-30 IS IS5280A patent/IS2619B/is unknown
- 1999-12-10 NO NO19996137A patent/NO323739B1/no not_active IP Right Cessation
-
2001
- 2001-05-16 HK HK01103404A patent/HK1032750A1/xx not_active IP Right Cessation
-
2003
- 2003-01-07 US US10/337,571 patent/US20040092477A1/en not_active Abandoned
-
2008
- 2008-03-31 CY CY20081100356T patent/CY1107912T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9810520A (pt) | Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial | |
BR0009564A (pt) | Utilização de inibidores da cyp2d6 em terapias de combinação | |
MA26548A1 (fr) | Compositions pharmaceutiques topiques contenant des derives de resorcinol. | |
BR9812699A (pt) | Derivados de benzamidina | |
BR0013704A (pt) | Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares | |
BRPI0414876A (pt) | compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos | |
BR0014078A (pt) | Inibidores de fator xa | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
BR0107147A (pt) | Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações | |
WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
BR9713400A (pt) | Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese. | |
BR9908280A (pt) | Inibidores de enzimas de fosfolipase | |
BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
MY125150A (en) | Factor vlla inhibitors | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
BR0005765A (pt) | Combinação de inibidores de aldose redutase e agentes anti-hipertensivos para o tratamento de complicações diabéticas | |
MY138394A (en) | Combination of mglur2 antagonist and ache inhibitor | |
WO2000045800A3 (en) | Immunosurpressive effects of pteridine derivatives | |
BR0110506A (pt) | Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose | |
MXPA05009986A (es) | Tratamiento de la enfermedad de alzheimer. | |
AU1023497A (en) | Tissue factor - kunitz domain fusion proteins as factor viia inhibitors | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
BR0206819A (pt) | Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: SANOFI-SYNTHELABO (FR) Free format text: TRANSFERIDO DE: AKZO NOBEL N.V. |
|
B25D | Requested change of name of applicant approved |
Owner name: SANOFI-AVENTIS (FR) Free format text: ALTERADO DE: SANOFI-SYNTHELABO |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O COMBINADO COM ART 13 DA LPI ) |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] |